The FDA is clear on this, you can either:
1. Get excellent clinical efficacy results with no safety issues and they don't really care about replicating the mechanism of action in-vivo with in-vitro, or;
2.
Source: https://pink.citeline.com/-/media/supporting-documents/pink-sheet/2020/08/fda-briefing-document-on-remestemcel-l-am-session.pdf?rev=222f51497a0f49c294091e6ad844115c&hash=93D88D09ED488698D719E3EA21DD7334
- Forums
- ASX - By Stock
- CYP
- The Phase I/IIb Nereid Study Is Now Registered
The Phase I/IIb Nereid Study Is Now Registered, page-20
Featured News
Add CYP (ASX) to my watchlist
(20min delay)
|
|||||
Last
33.5¢ |
Change
0.015(4.69%) |
Mkt cap ! $60.17M |
Open | High | Low | Value | Volume |
33.0¢ | 33.5¢ | 31.5¢ | $22.67K | 69.48K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 7864 | 33.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
34.0¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 7864 | 0.330 |
1 | 9995 | 0.325 |
1 | 300000 | 0.320 |
1 | 3350 | 0.315 |
2 | 16112 | 0.310 |
Price($) | Vol. | No. |
---|---|---|
0.345 | 29888 | 2 |
0.350 | 88892 | 1 |
0.385 | 50000 | 1 |
0.390 | 10000 | 1 |
0.400 | 6000 | 2 |
Last trade - 15.57pm 31/05/2024 (20 minute delay) ? |
|
|||||
Last
33.0¢ |
  |
Change
0.015 ( 4.76 %) |
|||
Open | High | Low | Volume | ||
33.0¢ | 33.0¢ | 31.5¢ | 20409 | ||
Last updated 15.48pm 31/05/2024 ? |
Featured News
CYP (ASX) Chart |